We serve Chemical Name:Hept-1-yne CAS:628-71-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Hept-1-yne
CAS.NO:628-71-7
Synonyms:I-Heptin;MFCD00009529;hept-1-yne;Amylacetylene;enanthylidene;1-Heptyne;1-n-heptyne;pentylacetylide;n-amylacetylene;EINECS 211-051-5;Hept-1-in
Molecular Formula:C7H12
Molecular Weight:96.170
HS Code:29012980
Physical and Chemical Properties:
Melting point:-81 °C
Boiling point:99.7±3.0 °C at 760 mmHg
Density:0.8±0.1 g/cm3
Index of Refraction:1.419
PSA:
Exact Mass:96.093903
LogP:3.12
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3295 3/PG 2
Packing Group:II
Contact us for information like I-Heptin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hept-1-in physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-n-heptyne Use and application,pentylacetylide technical grade,usp/ep/jp grade.
Related News: The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection. Hept-1-yne manufacturer First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. Hept-1-yne supplier The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection. Hept-1-yne vendor As the first-to-market BTK inhibitor, Imbruvica has been treating front-line CLL patients since its monotherapy go-ahead in early 2016. But it’s now facing competition from AstraZeneca’s Calquence, which just detailed a head-to-head safety advantage over Imbruvica in previously treated CLL. Hept-1-yne factory The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection.